[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2483 Enrolled Bill (ENR)]
H.R.2483
One Hundred Nineteenth Congress
of the
United States of America
AT THE FIRST SESSION
Begun and held at the City of Washington on Friday,
the third day of January, two thousand and twenty-five
An Act
To reauthorize certain programs that provide for opioid use disorder
prevention, treatment, and recovery, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

838a8894fe2261308cd8ca2420df98f5a5af9e99d8e5fcc6477bfa7f1de58156

(a) Short Title.--This Act may be cited as the ``SUPPORT for
Patients and Communities Reauthorization Act of 2025''.
(b) Table of Contents.--The table of contents for this Act is as
follows:

ae81368b6362715e0edf272ab78136065e6211971b3b562c997e9e199306fff8

595dfa1ae6b438b4aceb15c0c4a4828b2e15abe36a404a9e0d2b56715a7d8e6e

TITLE I

-PREVENTION

e5b0e57f8abe6398f8b3dccbdb131da5c25741b4f1d0bda7d245648ae246d59e

a9f2a65db0b9039fd4313686d8fce81229f6f4559e12bd433e7c8948ec8ecaca

ca45eec88177b9e274e91a32acc94dc7efa86100a6a86355d0e8bcbaa25be867

f6d3654d2d350e0d8129f6abe0cf17552f0b4ca2d376c31eb13c40ee34519447

TITLE II

-TREATMENT

00557917aab852ebc34b843e8374eb51a3e0456ec9f5dcad1d20f8444de25c5c

f9fc229ad5603e97715bc39f87e65accee05b787b376b723bcbf0209a5e54f18

2c1fa7d0670358c3cf28d8dd58aa830841b440fffe83a72a70183b1db4ebcc0c

illness and children with serious emotional disturbance.

2c04d4e19fd6fa7158954e08718a49a7c22c55d08ce871af6afb0ce6096a0262

combination of buprenorphine and naloxone.

d7cfc42801ce8adab3de51e4727be930330d608109500a387ce5f71172c28fe3

0a6ff1bb188b05e95a26ae2c03e65914c4e861a77eeb2aa1dedecbb35dfc8739

mental health and substance use care outcomes.

850a6804b2e2eb84155a17291215fc5e1f10a85c66622152880c92880f8d0f61

06c98c511d95618b61ba9fbce0bc3158abb4cc50664ff476a5fe57efb64f4b3f

TITLE III

-RECOVERY

995f997f5cc6969dd6c2fb461d8f9e3ca1410a73d64671d0a3fffd90ffccd805

ceec4bb5ee983255bad161ae5d8164fb5131e237e8b473e1ac7ddf2c48eb0dab

TITLE IV

-MISCELLANEOUS MATTERS

Section 317L(d) of the Public Health Service Act (42 U.S.C. 247b-
13(d)) is amended by striking ``such sums as may be necessary for each
of the fiscal years 2019 through 2023'' and inserting ``$4,250,000 for
each of fiscal years 2026 through 2030''.

4eba78b6761fdb7d64a161263d3e12e42dcd9431036fcc6dd7ed9c0ac5467235

WITH ILLICIT DRUG USE AND OTHER RISK FACTORS.
Section 317N(d) of the Public Health Service Act (42 U.S.C. 247b-
15(d)) is amended by striking ``fiscal years 2019 through 2023'' and
inserting ``fiscal years 2026 through 2030''.

852d0842576e5ae3c4781ffd2bb599ca079d0efb2933da90c7378097c0d6c361

(a) In General.--Section 392A of the Public Health Service Act (42
U.S.C. 280b-1) is amended--
(1) in subsection (a)(2)--
(A) in subparagraph (C), by inserting ``and associated
risks'' before the period at the end; and
(B) in subparagraph (D), by striking ``opioids'' and
inserting ``substances causing overdose''; and
(2) in subsection (b)(2)--
(A) in subparagraph (B), by inserting ``, and associated
risk factors,'' after ``such overdoses'';
(B) in subparagraph (C), by striking ``coding'' and
inserting ``monitoring and identifying'';
(C) in subparagraph (E)--
(i) by inserting a comma after ``public health
laboratories''; and
(ii) by inserting ``and other emerging substances
related'' after ``analogues''; and
(D) in subparagraph (F), by inserting ``and associated risk
factors'' after ``overdoses''.
(b) Additional Grants.--Section 392A(a)(3) of the Public Health
Service Act (42 U.S.C. 280b-1(a)(3)) is amended--
(1) in the matter preceding subparagraph (A), by striking ``and
Indian Tribes--'' and inserting ``and Indian Tribes for the
following purposes:'';
(2) by amending subparagraph (A) to read as follows:
``(A) To carry out innovative projects for grantees to
detect, identify, and rapidly respond to controlled substance
misuse, abuse, and overdoses, and associated risk factors,
including changes in patterns of such controlled substance use.
Such projects may include the use of innovative, evidence-based
strategies for detecting such patterns, such as wastewater
surveillance, if proven to support actionable prevention
strategies, in a manner consistent with applicable Federal and
State privacy laws.''; and
(3) in subparagraph (B), by striking ``for any'' and inserting
``For any''.
(c) Authorization of Appropriations.--Section 392A(e) of the Public
Health Service Act (42 U.S.C. 280b-1(e)) is amended by striking
``$496,000,000 for each of fiscal years 2019 through 2023'' and
inserting ``$505,579,000 for each of fiscal years 2026 through 2030''.

4165fde91e1cbf21f649cda89c89617eca88e08dd1e7d48857b7575df68ae4f0

ALCOHOL SPECTRUM DISORDER.
(a) In General.--Part O of title III of the Public Health Service
Act (42 U.S.C. 280f et seq.) is amended to read as follows:
``PART O--FETAL ALCOHOL SPECTRUM DISORDER PREVENTION AND SERVICES
PROGRAM
``SEC. 399H. FETAL ALCOHOL SPECTRUM DISORDERS PREVENTION, INTERVENTION,
AND SERVICES DELIVERY PROGRAM.
``(a) In General.--The Secretary shall establish or continue
activities to support a comprehensive fetal alcohol spectrum disorders
(referred to in this section as `FASD') education, prevention,
identification, intervention, and services delivery program, which may
include--
``(1) an education and public awareness program to support,
conduct, and evaluate the effectiveness of--
``(A) educational programs targeting health professions
schools, social and other supportive services, educators and
counselors and other service providers in all phases of
childhood development, and other relevant service providers,
concerning the prevention, identification, and provision of
services for infants, children, adolescents, and adults with
FASD;
``(B) strategies to educate school-age children, including
pregnant and high-risk youth, concerning FASD;
``(C) public and community awareness programs concerning
FASD; and
``(D) strategies to coordinate information and services
across affected community agencies, including agencies
providing social services such as foster care, adoption, and
social work, agencies providing health services, and agencies
involved in education, vocational training, and civil and
criminal justice;
``(2) supporting and conducting research on FASD, as
appropriate, including to--
``(A) develop appropriate medical diagnostic methods for
identifying FASD; and
``(B) develop effective culturally and linguistically
appropriate evidence-based or evidence-informed interventions
and appropriate supports for preventing prenatal alcohol
exposure, which may co-occur with exposure to other substances;
``(3) building State and Tribal capacity for the
identification, treatment, and support of individuals with FASD and
their families, which may include--
``(A) utilizing and adapting existing Federal, State, or
Tribal programs to include FASD identification and FASD-
informed support;
``(B) developing and expanding screening and diagnostic
capacity for FASD;
``(C) developing, implementing, and evaluating targeted
FASD-informed intervention programs for FASD;
``(D) providing training with respect to FASD for
professionals across relevant sectors; and
``(E) disseminating information about FASD and support
services to affected individuals and their families; and
``(4) an applied research program concerning intervention and
prevention to support and conduct service demonstration projects,
clinical studies and other research models providing advocacy,
educational and vocational training, counseling, medical and mental
health, and other supportive services, as well as models that
integrate and coordinate such services, that are aimed at the
unique challenges facing individuals with fetal alcohol spectrum
disorder or fetal alcohol effect and their families.
``(b) Grants and Technical Assistance.--
``(1) In general.--The Secretary may award grants, cooperative
agreements and contracts and provide technical assistance to
eligible entities to carry out subsection (a).
``(2) Eligible entities.--To be eligible to receive a grant, or
enter into a cooperative agreement or contract, under this section,
an entity shall--
``(A) be a State, Indian Tribe or Tribal organization,
local government, scientific or academic institution, or
nonprofit organization; and
``(B) prepare and submit to the Secretary an application at
such time, in such manner, and containing such information as
the Secretary may require, including a description of the
activities that the entity intends to carry out using amounts
received under this section.
``(3) Additional application contents.--The Secretary may
require that an eligible entity include in the application
submitted under paragraph (2)(B)--
``(A) a designation of an individual to serve as a FASD
State or Tribal coordinator of activities such eligible entity
proposes to carry out through a grant, cooperative agreement,
or contract under this section; and
``(B) a description of an advisory committee the entity
will establish to provide guidance for the entity on developing
and implementing a statewide or Tribal strategic plan to
prevent FASD and provide for the identification, treatment, and
support of individuals with FASD and their families.
``(c) Definition of FASD-Informed.--For purposes of this section,
the term `FASD-informed', with respect to support or an intervention
program, means that such support or intervention program uses
culturally and linguistically informed evidence-based or practice-based
interventions and appropriate resources to support an improved quality
of life for an individual with FASD and the family of such individual.
``SEC. 399I. STRENGTHENING CAPACITY AND EDUCATION FOR FETAL ALCOHOL
SPECTRUM DISORDERS.
``(a) In General.--The Secretary shall award grants, contracts, or
cooperative agreements, as the Secretary determines appropriate, to
public or nonprofit private entities with demonstrated expertise in the
field of fetal alcohol spectrum disorders (referred to in this section
as `FASD'). Such awards shall be for the purposes of building local,
Tribal, State, and nationwide capacities to prevent the occurrence of
FASD by carrying out the programs described in subsection (b).
``(b) Programs.--An entity receiving an award under subsection (a)
may use such award for the following purposes:
``(1) Developing and supporting public education and outreach
activities to raise public awareness of the risks associated with
alcohol consumption during pregnancy.
``(2) Acting as a clearinghouse for evidence-based resources on
FASD prevention, identification, and culturally and linguistically
appropriate best practices to help inform systems of care for
individuals with FASD across their lifespan.
``(3) Increasing awareness and understanding of efficacious,
evidence-based screening tools and culturally and linguistically
appropriate evidence-based intervention services and best
practices, which may include improving the capacity for State,
Tribal, and local affiliates.
``(4) Providing technical assistance to recipients of grants,
cooperative agreements, or contracts under section 399H, as
appropriate.
``(c) Application.--To be eligible for a grant, contract, or
cooperative agreement under this section, an entity shall submit to the
Secretary an application at such time, in such manner, and containing
such information as the Secretary may require.
``(d) Subcontracting.--A public or private nonprofit entity may
carry out the following activities required under this section through
contracts or cooperative agreements with other public and private
nonprofit entities with demonstrated expertise in FASD:
``(1) Resource development and dissemination.
``(2) Intervention services.
``(3) Training and technical assistance.
``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.
``There are authorized to be appropriated to carry out this part
$12,500,000 for each of fiscal years 2026 through 2030.''.
(b) Report.--Not later than 4 years after the date of enactment of
this Act, and every year thereafter, the Secretary of Health and Human
Services shall prepare and submit to the Committee on Health,
Education, Labor, and Pensions of the Senate and the Committee on
Energy and Commerce of the House of Representatives a report
containing--
(1) a review of the activities carried out pursuant to sections
399H and 399I of the Public Health Service Act, as amended, to
advance public education and awareness of fetal alcohol spectrum
disorders (referred to in this section as ``FASD'');
(2) a description of--
(A) the activities carried out pursuant to such sections
399H and 399I to identify, prevent, and treat FASD; and
(B) methods used to evaluate the outcomes of such
activities; and
(3) an assessment of activities carried out pursuant to such
sections 399H and 399I to support individuals with FASD.

0439cacb77888276a4badae71badeaa4056ecd87ef3a19e062685fede3dd3afe

Section 399O(h) of the Public Health Service Act (42 U.S.C. 280g-
3(h)) is amended by adding at the end the following:
``(5) Promoting state choice.--Nothing in this section shall be
construed to authorize the Secretary to require States to use a
specific vendor or a specific interoperability connection other
than to align with nationally recognized, consensus-based open
standards, such as in accordance with sections 3001 and 3004.''.

4a63e40eb5858213a5eac01d39639b0d8b86578f28d0e8b39152540329426541

Section 546 of the Public Health Service Act (42 U.S.C. 290ee-1) is
amended--
(1) in subsection (a), by striking ``tribes and tribal'' and
inserting ``Tribes and Tribal'';
(2) in subsections (a), (c), and (d)--
(A) by striking ``approved or cleared'' each place it
appears and inserting ``approved, cleared, or otherwise legally
marketed''; and
(B) by striking ``opioid'' each place it appears;
(3) in subsection (f)--
(A) by striking ``approved or cleared'' each place it
appears and inserting ``approved, cleared, or otherwise legally
marketed'';
(B) in paragraph (1), by striking ``opioid'';
(C) in paragraph (2)--
(i) by striking ``opioid and heroin'' and inserting
``opioid, heroin, and other drug''; and
(ii) by striking ``opioid overdose'' and inserting
``overdose''; and
(D) in paragraph (3), by striking ``opioid and heroin'';
and
(4) in subsection (h), by striking ``$36,000,000 for each of
fiscal years 2019 through 2023'' and inserting ``$57,000,000 for
each of fiscal years 2026 through 2030''.

7763ef258c4ca37eed3c9815c45d6cd9e129260242b5ac48a2d368ae44623d9b

INITIATIVE.
(a) Technical Amendment.--The second part G of title V of the
Public Health Service Act (42 U.S.C. 290kk et seq.), as added by
section 144 of the Community Renewal Tax Relief Act of 2000 (Public Law
106-554), is amended--
(1) by redesignating such part as part J; and
(2) by redesignating sections 581 through 584 as sections 596
through 596C, respectively.
(b) In General.--Section 582 of the Public Health Service Act (42
U.S.C. 290hh-1) is amended--
(1) in the section heading, by striking ``violence related
stress'' and inserting ``traumatic events'';
(2) in subsection (a)--
(A) in the matter preceding paragraph (1), by striking
``tribes and tribal'' and inserting ``Tribes and Tribal''; and
(B) in paragraph (2), by inserting ``and dissemination''
after ``the development'';
(3) in subsection (b), by inserting ``and dissemination'' after
``the development'';
(4) in subsection (d)--
(A) by striking ``The NCTSI'' and inserting the following:
``(1) Coordinating center.--The NCTSI''; and
(B) by adding at the end the following:
``(2) NCTSI grantees.--In carrying out subsection (a)(2), NCTSI
grantees shall develop trainings and other resources, as applicable
and appropriate, to support implementation of the evidence-based
practices developed and disseminated under such subsection.'';
(5) in subsection (e)--
(A) by redesignating paragraphs (1) and (2) as
subparagraphs (A) and (B), respectively, and adjusting the
margins accordingly;
(B) in subparagraph (A), as so redesignated, by inserting
``and implementation'' after ``the dissemination'';
(C) by striking ``The NCTSI'' and inserting the following:
``(1) Coordinating center.--The NCTSI''; and
(D) by adding at the end the following:
``(2) NCTSI grantees.--NCTSI grantees shall, as appropriate,
collaborate with other such grantees, the NCTSI coordinating
center, and the Secretary in carrying out subsections (a)(2) and
(d)(2).'';
(6) by amending subsection (h) to read as follows:
``(h) Application and Evaluation.--To be eligible to receive a
grant, contract, or cooperative agreement under subsection (a), a
public or nonprofit private entity or an Indian Tribe or Tribal
organization shall submit to the Secretary an application at such time,
in such manner, and containing such information and assurances as the
Secretary may require, including--
``(1) a plan for the evaluation of the activities funded under
the grant, contract, or agreement, including both process and
outcomes evaluation, and the submission of an evaluation at the end
of the project period; and
``(2) a description of how such entity, Indian Tribe, or Tribal
organization will support efforts led by the Secretary or the NCTSI
coordinating center, as applicable, to evaluate activities carried
out under this section.''; and
(7) by amending subsection (j) to read as follows:
``(j) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section--
``(1) $98,887,000 for fiscal year 2026;
``(2) $98,887,000 for fiscal year 2027;
``(3) $98,887,000 for fiscal year 2028;
``(4) $100,000,000 for fiscal year 2029; and
``(5) $100,000,000 for fiscal year 2030.''.

c4dd39df505a369b512fc47d75986b52199c84668a63b8eb73c64d02b68edea4

INCIDENTS.
(a) National Suicide Prevention Lifeline Program.--Section 520E-
3(b) of the Public Health Service Act (42 U.S.C. 290bb-36c(b)) is
amended--
(1) in paragraph (4), by striking ``and'' at the end;
(2) in paragraph (5), by striking the period at the end and
inserting ``; and''; and
(3) by adding at the end the following:
``(6) taking such steps as may be necessary to ensure the
suicide prevention hotline is protected from cybersecurity
incidents and eliminates known cybersecurity vulnerabilities.''.
(b) Reporting.--Section 520E-3 of the Public Health Service Act (42
U.S.C. 290bb-36c) is amended--
(1) by redesignating subsection (f) as subsection (g); and
(2) by inserting after subsection (e) the following:
``(f) Cybersecurity Reporting.--
``(1) Notification.--
``(A) In general.--The program's network administrator
receiving Federal funding pursuant to subsection (a) shall
report to the Assistant Secretary, in a manner that protects
personal privacy, consistent with applicable Federal and State
privacy laws--
``(i) any identified cybersecurity vulnerabilities to
the program within a reasonable amount of time after
identification of such a vulnerability; and
``(ii) any identified cybersecurity incidents to the
program within a reasonable amount of time after
identification of such incident.
``(B) Local and regional crisis centers.--Local and
regional crisis centers participating in the program shall
report to the program's network administrator identified under
subparagraph (A), in a manner that protects personal privacy,
consistent with applicable Federal and State privacy laws--
``(i) any identified cybersecurity vulnerabilities to
the program within a reasonable amount of time after
identification of such vulnerability; and
``(ii) any identified cybersecurity incidents to the
program within a reasonable amount of time after
identification of such incident.
``(2) Notification.--If the program's network administrator
receiving funding pursuant to subsection (a) discovers, or is
informed by a local or regional crisis center pursuant to paragraph
(1)(B) of, a cybersecurity vulnerability or incident, within a
reasonable amount of time after such discovery or receipt of
information, such entity shall report the vulnerability or incident
to the Assistant Secretary.
``(3) Clarification.--
``(A) Oversight.--
``(i) Local and regional crisis centers.--Except as
provided in clause (ii), local and regional crisis centers
participating in the program shall oversee all technology
each center employs in the provision of services as a
participant in the program.
``(ii) Network administrator.--The program's network
administrator receiving Federal funding pursuant to
subsection (a) shall oversee the technology each crisis
center employs in the provision of services as a
participant in the program if such oversight
responsibilities are established in the applicable network
participation agreement.
``(B) Supplement, not supplant.--The cybersecurity incident
reporting requirements under this subsection shall supplement,
and not supplant, cybersecurity incident reporting requirements
under other provisions of applicable Federal law that are in
effect on the date of the enactment of the SUPPORT for Patients
and Communities Reauthorization Act of 2025.''.
(c) Study.--Not later than 180 days after the date of the enactment
of this Act, the Comptroller General of the United States shall--
(1) conduct and complete a study that evaluates cybersecurity
risks and vulnerabilities associated with the 9-8-8 National
Suicide Prevention Lifeline; and
(2) submit a report on the findings of such study to the
Committee on Health, Education, Labor, and Pensions of the Senate
and the Committee on Energy and Commerce of the House of
Representatives.

062d3f0c2ed6f1c8390c4fa0143c207e562c4b0df333b6358c6f07666d795992

TRAUMA.
Section 7131(e) of the SUPPORT for Patients and Communities Act (42
U.S.C. 242t(e)) is amended by striking ``$2,000,000 for each of fiscal
years 2019 through 2023'' and inserting ``$9,000,000 for each of fiscal
years 2026 through 2030''.

d98c6a6082e7f04e00f9cf6da6d98bee10bc9f5ae0485364a3045d4401e07900

(a) Youth Prevention and Recovery.--Section 7102(c) of the SUPPORT
for Patients and Communities Act (42 U.S.C. 290bb-7a(c)) is amended--
(1) in paragraph (3)(A)(i), by inserting ``, which may include
strategies to increase education and awareness of the potency and
dangers of synthetic opioids (including drugs contaminated with
fentanyl) and, as appropriate, other emerging drug use or misuse
issues'' before the semicolon; and
(2) in paragraph (4)(A), by inserting ``and strategies to
increase education and awareness of the potency and dangers of
synthetic opioids (including drugs contaminated with fentanyl) and,
as appropriate, emerging drug use or misuse issues'' before the
semicolon.
(b) Interdepartmental Substance Use Disorders Coordinating
Committee.--Section 7022 of the SUPPORT for Patients and Communities
Act (42 U.S.C. 290aa note) is amended--
(1) by striking subsection (g) and inserting the following:
``(g) Working Groups.--
``(1) In general.--The Committee may establish working groups
for purposes of carrying out the duties described in subsection
(e). Any such working group shall be composed of members of the
Committee (or the designees of such members) and may hold such
meetings as are necessary to carry out the duties delegated to the
working group.
``(2) Additional federal interagency work group on fentanyl
contamination of illegal drugs.--
``(A) Establishment.--The Secretary, acting through the
Committee, shall establish a Federal Interagency Work Group on
Fentanyl Contamination of Illegal Drugs (referred to in this
paragraph as the `Work Group') consisting of representatives
from relevant Federal departments and agencies on the
Committee.
``(B) Consultation.--The Work Group shall consult with
relevant stakeholders and subject matter experts, including--
``(i) State, Tribal, and local subject matter experts
in reducing, preventing, and responding to drug overdose
caused by fentanyl contamination of illicit drugs; and
``(ii) family members of both adults and youth who have
overdosed by fentanyl contaminated illicit drugs.
``(C) Duties.--The Work Group shall--
``(i) examine Federal efforts to reduce and prevent
drug overdose by fentanyl-contaminated illicit drugs;
``(ii) identify strategies to improve State, Tribal,
and local responses to overdose by fentanyl-contaminated
illicit drugs;
``(iii) coordinate with the Secretary, as appropriate,
in carrying out activities to raise public awareness of
synthetic opioids and other emerging drug use and misuse
issues;
``(iv) make recommendations to Congress for improving
Federal programs, including with respect to the
coordination of efforts across such programs; and
``(v) make recommendations for educating youth on the
potency and dangers of drugs contaminated by fentanyl.
``(D) Annual report to secretary.--The Work Group shall
annually prepare and submit to the Secretary, the Committee on
Health, Education, Labor, and Pensions of the Senate, and the
Committee on Energy and Commerce and the Committee on Education
and Workforce of the House of Representatives, a report on the
activities carried out by the Work Group under subparagraph
(C), including recommendations to reduce and prevent drug
overdose by fentanyl contamination of illegal drugs, in all
populations, and specifically among youth at risk for substance
misuse.''; and
(2) by striking subsection (i) and inserting the following:
``(i) Sunset.--The Committee shall terminate on September 30,
2030.''.

6d95ae224911918d8b60d9047190d1dc875ab32cbe70bf4faf20a7e045fdc145

(a) In General.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services, in
consultation with the Administrator of the Drug Enforcement
Administration, shall publish guidance to facilitate the use of at-home
safe disposal systems for applicable drugs.
(b) Contents.--The guidance under subsection (a) shall include--
(1) recommended standards for effective at-home drug disposal
systems to meet applicable requirements enforced by the Food and
Drug Administration;
(2) recommended information to include as instructions for use
to disseminate with at-home drug disposal systems;
(3) best practices and educational tools to support the use of
an at-home drug disposal system, as appropriate; and
(4) recommended use of licensed health providers for the
dissemination of education, instruction, and at-home drug disposal
systems, as appropriate.

f84197ae0ec6842a63ee74414580181be1fc9b341404185f40a1d1a2288f2e8e

(a) In General.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services
(referred to in this section as the ``Secretary'') shall publish on the
website of the Food and Drug Administration (referred to in this
section as the ``FDA'') a report that outlines a plan for assessing
opioid analgesic drugs that are approved under section 505 of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) that addresses the
public health effects of such opioid analgesic drugs as part of the
benefit-risk assessment and the activities of the FDA that relate to
facilitating the development of nonaddictive medical products intended
to treat pain or addiction. Such report shall include--
(1) an update on the actions taken by the FDA to consider the
effectiveness, safety, benefit-risk profile, and use of approved
opioid analgesic drugs;
(2) a timeline for an assessment of the potential need, as
appropriate, for labeling changes, revised or additional
postmarketing requirements, enforcement actions, or withdrawals for
opioid analgesic drugs;
(3) an overview of the steps that the FDA has taken to support
the development and approval of nonaddictive medical products
intended to treat pain or addiction, and actions planned to further
support the development and approval of such products; and
(4) an overview of the consideration by the FDA of clinical
trial methodologies for analgesic drugs, including the enriched
enrollment randomized withdrawal methodology, and the benefits and
drawbacks associated with different trial methodologies for such
drugs, incorporating any public input received under subsection
(b).
(b) Public Input.--In carrying out subsection (a), the Secretary
shall provide an opportunity for public input concerning the regulation
by the FDA of opioid analgesic drugs, including scientific evidence
that relates to conditions of use, safety, or benefit-risk assessment
(including consideration of the public health effects) of such opioid
analgesic drugs.

98158c4141950496293d4853d35e9c116b9514c798b476b3dac2209321f386ca

DISORDERS.
The activities carried out pursuant to section 1003(b)(4)(A) of the
21st Century Cures Act (42 U.S.C. 290ee-3a(b)(4)(A)) may include
facilitating access to products used to prevent overdose deaths by
detecting the presence of one or more substances, such as fentanyl and
xylazine test strips, to the extent the purchase and possession of such
products is consistent with Federal and State law.

1692227fc893a13fb9a681e763c6d1b7a67471a84e53549dab72347bfc0950b5

WOMEN.
Section 508 of the Public Health Service Act (42 U.S.C. 290bb-1) is
amended--
(1) in subsection (d)(11)(C), by striking ``providing health
services'' and inserting ``providing health care services'';
(2) in subsection (g)--
(A) by inserting ``a plan describing'' after ``will
provide''; and
(B) by adding at the end the following: ``Such plan may
include a description of how such applicant will target
outreach to women disproportionately impacted by maternal
substance use disorder.''; and
(3) in subsection (s), by striking ``$29,931,000 for each of
fiscal years 2019 through 2023'' and inserting ``$38,931,000 for
each of fiscal years 2026 through 2030''.

83ec5c4b31edcc63581fd8092470d16e8bbbcc126a7f7072848bd32f30884c11

Section 597 of the Public Health Service Act (42 U.S.C. 290ll) is
amended--
(1) in subsection (a)(1), by inserting ``diagnosis,'' after
``related to''; and
(2) in subsection (b), by inserting ``addiction medicine,''
after ``psychiatry,''.

dfc2aaa912e10e7770c4e841a0dedd7d538f1d569ae793278cf5099c60494a45

GRANTS.
Section 756(f) of the Public Health Service Act (42 U.S.C. 294e-
1(f)) is amended by striking ``fiscal years 2023 through 2027'' and
inserting ``fiscal years 2026 through 2030''.

25fac8dd2d4415596ac755817e588436066ee4dedafc888fbc8b89ae10c24731

TREATMENT WORKFORCE.
Section 781(j) of the Public Health Service Act (42 U.S.C. 295h(j))
is amended by striking ``$25,000,000 for each of fiscal years 2019
through 2023'' and inserting ``$40,000,000 for each of fiscal years
2026 through 2030''.

46bfad9c159e6fb35feed61be3cbb540e8a62052eabfd9023e5b548c237bd2cb

FOR SUBSTANCE USE DISORDER PATIENT RECORDS.
Section 7053 of the SUPPORT for Patients and Communities Act (42
U.S.C. 290dd-2 note) is amended by striking subsection (e).

ea131624e5e4ae00083cdcf690b847525b66afdbb3d8653c3e4d3fd3eebea1c8

IDENTIFICATION, REFERRAL, AND SUPPORT.
Section 7132 of the SUPPORT for Patients and Communities Act
(Public Law 115-271; 132 Stat. 4046) is amended--
(1) in subsection (b)(1)--
(A) by redesignating subparagraph (CC) as subparagraph
(DD); and
(B) by inserting after subparagraph (BB) the following:
``(CC) The Administration for Community Living.'';
(2) in subsection (d)(1), in the matter preceding subparagraph
(A), by inserting ``, developmental disability service providers''
before ``, individuals who are''; and
(3) in subsection (i), by striking ``2023'' and inserting
``2030''.

0019e86f1e4ab22b40e8508236c99a9750d0f1f414d1da0adc450da13549f840

TREATMENT.
Section 3203 of the SUPPORT for Patients and Communities Act (21
U.S.C. 823 note) is amended--
(1) by striking subsection (b); and
(2) by striking ``(a) In General.--The Secretary'' and
inserting the following: ``The Secretary''.

44bd61e459593725f5ca6573dc5e601473cceb159faca2579f4a1fcc5d132bfb

ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCE.
(a) Review of Use of Certain Funding.--Not later than 1 year after
the date of enactment of this Act, the Secretary of Health and Human
Services (referred to in this section as the ``Secretary''), acting
through the Assistant Secretary for Mental Health and Substance Use,
shall conduct a review of State use of funds made available under the
Community Mental Health Services Block Grant program under subpart I of
part B of title XIX of the Public Health Service Act (42 U.S.C. 300x et
seq.) (referred to in this section as the ``block grant program'') for
first episode psychosis activities. Such review shall consider the
following:
(1) How States use funds for evidence-based treatments and
services according to the standard of care for individuals with
early serious mental illness and children with a serious emotional
disturbance.
(2) The percentages of the State funding under the block grant
program expended on early serious mental illness and first episode
psychosis, and the number of individuals served under such funds.
(b) Report and Guidance.--
(1) Report.--Not later than 180 days after the completion of
the review under subsection (a), the Secretary shall submit to the
Committee on Health, Education, Labor, and Pensions and the
Committee on Appropriations of the Senate and the Committee on
Energy and Commerce and the Committee on Appropriations of the
House of Representatives a report describing--
(A) the findings of the review under subsection (a); and
(B) any recommendations for changes to the block grant
program that would facilitate improved outcomes for individuals
with serious mental illness and children with serious emotional
disturbance.
(2) Guidance.--Not later than 1 year after the date on which
the report is submitted under paragraph (1), the Secretary shall
update the guidance provided to States under the block grant
program on coordinated specialty care and other evidence-based
mental health care services for individuals with serious mental
illness and children with a serious emotional disturbance, based on
the findings and recommendations of such report.

2dafef2c9f1aee2bf61a86cab61b11067a3f35c1b5d1e9e32016d4b8f46253d6

A COMBINATION OF BUPRENORPHINE AND NALOXONE.
(a) Secretary of HHS.--The Secretary of Health and Human Services
shall, consistent with the requirements and procedures set forth in
sections 201 and 202 of the Controlled Substances Act (21 U.S.C. 811,
812)--
(1) review the relevant data pertaining to the scheduling of
products containing a combination of buprenorphine and naloxone
that have been approved under section 505 of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 355); and
(2) if appropriate, request that the Attorney General initiate
rulemaking proceedings to revise the schedules accordingly with
respect to such products.
(b) Attorney General.--The Attorney General shall review any
request made by the Secretary of Health and Human Services under
subsection (a)(2) and determine whether to initiate proceedings to
revise the schedules in accordance with the criteria set forth in
sections 201 and 202 of the Controlled Substances Act (21 U.S.C. 811,
812).

cb1dc5247e5f2c9adfbc6a93a287f1267e5cc6dce37dee82f1d1038dd0efe204

GRANT PROGRAMS.
(a) In General.--The Secretary of Health and Human Services shall
ensure that, as appropriate, whenever the Department of Health and
Human Services issues a regulation or guidance for any grant program
addressing opioid misuse and use disorders, any reference to an opioid
overdose reversal drug (such as a reference to naloxone) is inclusive
of any opioid overdose reversal drug that has been approved under
section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355)
for emergency treatment of a known or suspected opioid overdose.
(b) Existing References.--
(1) Update.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services
shall update all references described in paragraph (2) to be
inclusive of any opioid overdose reversal drug that has been
approved or otherwise authorized for use by the Food and Drug
Administration.
(2) References.--A reference described in this paragraph is any
reference to an opioid overdose reversal drug (such as naloxone) in
any regulation or guidance of the Department of Health and Human
Services that--
(A) was issued before the date of enactment of this Act;
and
(B) is included in--
(i) the grant program for State and Tribal response to
opioid use disorders under section 1003 of the 21st Century
Cures Act (42 U.S.C. 290ee-3 note) (commonly referred to as
``State Opioid Response Grants'' and ``Tribal Opioid
Response Grants''); or
(ii) the grant program for priority substance use
disorder prevention needs of regional and national
significance under section 516 of the Public Health Service
Act (42 U.S.C. 290bb-22).

99122260f192b9bbef12c33f7a805707d0fe235753d686b66ef17c2b92487d4c

IMPROVE MENTAL HEALTH AND SUBSTANCE USE CARE OUTCOMES.
(a) Roundtable.--Not later than 180 days after the date of
enactment of this Act, the National Coordinator for Health Information
Technology shall convene a public roundtable to examine--
(1) how the expanded use of electronic health records among
mental health and substance use service providers can improve
outcomes for patients in mental health and substance use settings;
and
(2) how best to increase electronic health record adoption
among such providers.
(b) Participants.--The National Coordinator for Health Information
Technology shall ensure that the participants in the roundtable under
subsection (a) include private and public sector stakeholders,
including patients, providers (including providers of inpatient
services and providers of outpatient services), and representatives of
payors, health information exchanges, professional associations, health
information technology vendors, health information technology
certification organizations, and State and Federal agencies.
(c) Report.--Not later than 180 days after the conclusion of the
public stakeholder roundtable under subsection (a), the National
Coordinator for Health Information Technology shall submit to the
Committee on Health, Education, Labor, and Pensions of the Senate and
the Committee on Energy and Commerce of the House of Representatives a
report outlining information gathered from the roundtable under
subsection (a). Such report shall include an examination of--
(1) recommendations from the roundtable participants;
(2) unique considerations for using electronic health record
systems in mental health and substance use treatment settings;
(3) unique considerations for developers of health information
technology relating to certification of electronic health record
systems for use in mental health and substance use treatment
settings where the applicable health information technology is not
subject to certification requirements;
(4) current usage of electronic health record systems by mental
health and substance use disorder service providers, and the scope
and magnitude of such providers that do not use electronic health
record systems;
(5) examples of how electronic health record systems enable
coordinated care and care management;
(6) how electronic health record systems advance appropriate
patient and provider access to secure, usable electronic
information exchange;
(7) how electronic health record systems can be connected to or
support existing systems, which may include the 9-8-8 National
Suicide Prevention Lifeline, mobile crisis response systems, and
co-responder programs, to facilitate connectivity, response, and
integrated care;
(8) any existing programs to support greater adoption of
electronic health record systems among mental health and substance
use service providers;
(9) any limitations to greater adoption of electronic health
record systems among mental health and substance use service
providers;
(10) the costs of adoption of electronic health record systems
by mental health and substance use disorder service providers; and
(11) best practices implemented by States and other entities to
support adoption of use of electronic health records among mental
health and substance use disorder service providers.

17b422c2c8d101eaebc2ede9a8a1665ff34f07918a2276d1df1092dc46fd3b87

Section 547(f) of the Public Health Service Act (42 U.S.C. 290ee-
2(f)) is amended by striking ``$5,000,000 for each of fiscal years 2019
through 2023'' and inserting ``$17,000,000 for each of fiscal years
2026 through 2030''.

9ee66e419f9bf89444184cd5c93dcda872fa3741ee70752617a4d4e4a8b452af

Section 547A of the Public Health Service Act (42 U.S.C. 290ee-2a)
is amended--
(1) in subsection (b)(4), by striking ``building; and'' and
inserting the following: ``building, such as--
``(A) professional development of peer support specialists;
and
``(B) making recovery support services available in
nonclinical settings; and'';
(2) by redesignating subsections (d) and (e) as subsections (e)
and (f), respectively;
(3) by inserting after subsection (c) the following:
``(d) Regional Centers.--
``(1) In general.--The Secretary may establish one regional
technical assistance center (referred to in this subsection as the
`Regional Center'), with existing resources, to assist the Center
in carrying out activities described in subsection (b) within the
geographic region of such Regional Center in a manner that is
tailored to the needs of such region.
``(2) Evaluation.--Not later than 4 years after the date of
enactment of the SUPPORT for Patients and Communities
Reauthorization Act of 2025, the Secretary shall evaluate the
activities of the Regional Center and submit to the Committee on
Health, Education, Labor, and Pensions of the Senate and the
Committee on Energy and Commerce of the House of Representatives a
report on the findings of such evaluation, including--
``(A) a description of the distinct roles and
responsibilities of the Regional Center and the Center;
``(B) available information relating to the outcomes of the
Regional Center under this subsection, such as any impact on
the operations and efficiency of the Center relating to
requests for technical assistance and support within the region
of such Regional Center;
``(C) a description of any gaps or areas of duplication
relating to the activities of the Regional Center and the
Center within such region; and
``(D) recommendations relating to the modification,
expansion, or termination of the Regional Center under this
subsection.
``(3) Termination.--This subsection shall terminate on
September 30, 2030.''; and
(4) in subsection (f), as so redesignated, by striking
``$1,000,000 for each of fiscal years 2019 through 2023'' and
inserting ``$2,000,000 for each of fiscal years 2026 through
2030''.

39f312815f7393db5d1a8f284554c7809b2d1d8b38019658f00b1cdb7ab2d370

Section 552 of the Public Health Service Act (42 U.S.C. 290ee-7) is
amended--
(1) in subsection (d)(2)--
(A) in the matter preceding subparagraph (A), by striking
``and in such manner'' and inserting ``, in such manner, and
containing such information and assurances, including relevant
documentation,''; and
(B) in subparagraph (A), by striking ``is capable of
coordinating with other entities to carry out'' and inserting
``has the demonstrated capability to carry out, through
referral or contractual arrangements'';
(2) in subsection (h)--
(A) by redesignating paragraphs (1) through (4) as
subparagraphs (A) through (D), respectively, and adjusting the
margins accordingly;
(B) by striking ``With respect to'' and inserting the
following:
``(1) In general.--With respect to''; and
(C) by adding at the end the following:
``(2) Additional reporting for certain eligible entities.--An
entity carrying out activities described in subsection (g) through
referral or contractual arrangements shall include in the
submissions required under paragraph (1) information related to the
status of such referrals or contractual arrangements, including an
assessment of whether such referrals or contractual arrangements
are supporting the ability of such entity to carry out such
activities.''; and
(3) in subsection (j), by striking ``2019 through 2023'' and
inserting ``2026 through 2030''.

09c645cb1ddb237bfec01d3291efb0457956f6edf6bbbaa7b2daa809296e05a9

Section 7102(c) of the SUPPORT for Patients and Communities Act (42
U.S.C. 290bb-7a(c)) (as amended by section 110(a)) is amended--
(1) in paragraph (2)--
(A) in subparagraph (A)--
(i) in clause (i)--
(I) by inserting ``, or a consortium of local
educational agencies,'' after ``a local educational
agency''; and
(II) by striking ``high schools'' and inserting
``secondary schools''; and
(ii) in clause (vi), by striking ``tribe, or tribal''
and inserting ``Tribe, or Tribal'';
(B) by amending subparagraph (E) to read as follows:
``(E) Indian tribe; tribal organization.--The terms `Indian
Tribe' and `Tribal organization' have the meanings given such
terms in section 4 of the Indian Self-Determination and
Education Assistance Act (25 U.S.C. 5304).'';
(C) by redesignating subparagraph (K) as subparagraph (L);
and
(D) by inserting after subparagraph (J) the following:
``(K) Secondary school.--The term `secondary school' has
the meaning given such term in section 8101 of the Elementary
and Secondary Education Act of 1965 (20 U.S.C. 7801).'';
(2) in paragraph (3)(A), in the matter preceding clause (i)--
(A) by striking ``and abuse''; and
(B) by inserting ``at increased risk for substance misuse''
after ``specific populations'';
(3) in paragraph (4)--
(A) in the matter preceding subparagraph (A), by striking
``Indian tribes'' and inserting ``Indian Tribes'';
(B) in subparagraph (A), by striking ``and abuse''; and
(C) in subparagraph (B), by striking ``peer mentoring'' and
inserting ``peer-to-peer support'';
(4) in paragraph (5), by striking ``tribal'' and inserting
``Tribal'';
(5) in paragraph (6)(A)--
(A) in clause (iv), by striking ``; and'' and inserting a
semicolon; and
(B) by adding at the end the following:
``(vi) a plan to sustain the activities carried out
under the grant program, after the grant program has ended;
and'';
(6) in paragraph (8), by striking ``2022'' and inserting
``2028''; and
(7) by amending paragraph (9) to read as follows:
``(9) Authorization of appropriations.--To carry out this
subsection, there are authorized to be appropriated--
``(A) $10,000,000 for fiscal year 2026;
``(B) $12,000,000 for fiscal year 2027;
``(C) $13,000,000 for fiscal year 2028;
``(D) $14,000,000 for fiscal year 2029; and
``(E) $15,000,000 for fiscal year 2030.''.

75105d3a8884a8c60af2b59a1db6dab67280a9a2defb3a61053dadcb052f7ab7

(a) In General.--Section 7183 of the SUPPORT for Patients and
Communities Act (42 U.S.C. 290ee-8) is amended--
(1) in the section heading, by inserting ``; treatment,
recovery, and workforce support grants'' after ``career act'';
(2) in subsection (b), by inserting ``each'' before ``for a
period'';
(3) in subsection (c)--
(A) in paragraph (1), by striking ``the rates described in
paragraph (2)'' and inserting ``the average rates for calendar
years 2018 through 2022 described in paragraph (2)''; and
(B) by amending paragraph (2) to read as follows:
``(2) Rates.--The rates described in this paragraph are the
following:
``(A) The highest age-adjusted average rates of drug
overdose deaths for calendar years 2018 through 2022 based on
data from the Centers for Disease Control and Prevention,
including, if necessary, provisional data for calendar year
2022.
``(B) The highest average rates of unemployment for
calendar years 2018 through 2022 based on data provided by the
Bureau of Labor Statistics.
``(C) The lowest average labor force participation rates
for calendar years 2018 through 2022 based on data provided by
the Bureau of Labor Statistics.'';
(4) in subsection (g)--
(A) in each of paragraphs (1) and (3), by redesignating
subparagraphs (A) and (B) as clauses (i) and (ii),
respectively, and adjusting the margins accordingly;
(B) by redesignating paragraphs (1) through (3) as
subparagraphs (A) through (C), respectively, and adjusting the
margins accordingly;
(C) in the matter preceding subparagraph (A) (as so
redesignated), by striking ``An entity'' and inserting the
following:
``(1) In general.--An entity''; and
(D) by adding at the end the following:
``(2) Transportation services.--An entity receiving a grant
under this section may use not more than 5 percent of the funds for
providing transportation for individuals to participate in an
activity supported by a grant under this section, which
transportation shall be to or from a place of work or a place where
the individual is receiving vocational education or job training
services or receiving services directly linked to treatment of or
recovery from a substance use disorder.
``(3) Limitation.--The Secretary may not require an entity to,
or give priority to an entity that plans to, use the funds of a
grant under this section for activities that are not specified in
this subsection.'';
(5) in subsection (i)(2), by inserting ``, which shall include
employment and earnings outcomes described in subclauses (I) and
(III) of section 116(b)(2)(A)(i) of the Workforce Innovation and
Opportunity Act (29 U.S.C. 3141(b)(2)(A)(i)) with respect to the
participation of such individuals with a substance use disorder in
programs and activities funded by the grant under this section''
after ``subsection (g)'';
(6) in subsection (j)--
(A) in paragraph (1), by inserting ``for grants awarded
prior to the date of enactment of the SUPPORT for Patients and
Communities Reauthorization Act of 2025'' after ``grant period
under this section''; and
(B) in paragraph (2)--
(i) in the matter preceding subparagraph (A), by
striking ``2 years after submitting the preliminary report
required under paragraph (1)'' and inserting ``September
30, 2030''; and
(ii) in subparagraph (A), by striking ``(g)(3)'' and
inserting ``(g)(1)(C)''; and
(7) in subsection (k), by striking ``$5,000,000 for each of
fiscal years 2019 through 2023'' and inserting ``$12,000,000 for
each of fiscal years 2026 through 2030''.
(b) Reauthorization of the CAREER Act; Recovery Housing Pilot
Program.--
(1) In general.--Section 8071 of the SUPPORT for Patients and
Communities Act (42 U.S.C. 5301 note; Public Law 115-271) is
amended--
(A) by striking the section heading and inserting ``career
act; recovery housing pilot program'';
(B) in subsection (a), by striking ``through 2023'' and
inserting ``through 2030'';
(C) in subsection (b)--
(i) in paragraph (1), by striking ``not later than 60
days after the date of enactment of this Act'' and
inserting ``not later than 60 days after the date of
enactment of the SUPPORT for Patients and Communities
Reauthorization Act of 2025''; and
(ii) in paragraph (2)(B)(i)--
(I) in subclause (I)--
(aa) by striking ``for calendar years 2013
through 2017''; and
(bb) by inserting ``for calendar years 2018
through 2022'' after ``rates of unemployment'';
(II) in subclause (II)--
(aa) by striking ``for calendar years 2013
through 2017''; and
(bb) by inserting ``for calendar years 2018
through 2022'' after ``participation rates''; and
(III) by striking subclause (III) and inserting the
following:
``(III) The highest age-adjusted average rates of
drug overdose deaths for calendar years 2018 through
2022 based on data from the Centers for Disease Control
and Prevention, including, if necessary, provisional
data for calendar year 2022.''; and
(D) in subsection (f), by striking ``For the 2-year period
following the date of enactment of this Act, the'' and
inserting ``The''.
(2) Conforming amendment.--Subtitle F of title VIII of the
SUPPORT for Patients and Communities Act (Public Law 115-271; 132
Stat. 4095) is amended by striking the subtitle heading and
inserting the following: ``Subtitle F--CAREER Act; Recovery Housing
Pilot Program'' .
(c) Clerical Amendments.--The table of contents in section 1(b) of
the SUPPORT for Patients and Communities Act (Public Law 115-271; 132
Stat. 3894) is amended--
(1) by striking the item relating to section 7183 and inserting
the following:
``Sec. 7183. CAREER Act; treatment, recovery, and workforce support
grants.'';
(2) by striking the item relating to subtitle F of title VIII
and inserting the following:
``Subtitle F--CAREER Act; Recovery Housing Pilot Program''; and
(3) by striking the item relating to section 8071 and inserting
the following:
``Sec. 8071. CAREER Act; Recovery Housing Pilot Program.''.

964719e7ef6af241b1b01241274c9f75a7de452caba9a52454ffd7182afe7d68

CRISIS.
Section 8041(g)(1) of the SUPPORT for Patients and Communities Act
(29 U.S.C. 3225a(g)(1)) is amended by striking ``2023'' and inserting
``2030''.

47851fb50f14f586f04d6d861ed8ff4fe00ff5cf7312743edf9b4d6fec35dca3

UNDER PROGRAMS ADMINISTERED BY SAMHSA.
(a) In General.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services
(referred to in this section as the ``Secretary'') shall convene a
public meeting for purposes of improving awareness of, and access to,
information related to current and future funding opportunities under
programs administered by the Substance Abuse and Mental Health Services
Administration (in this section referred to as ``SAMHSA funding
opportunities'').
(b) Topics.--The public meeting under subsection (a) shall
include--
(1) opportunities to improve the utility and functionality of
internet websites maintained by the Secretary that provide
information related to SAMHSA funding opportunities, such as
Grants.gov;
(2) other models for displaying and disseminating information
related to SAMHSA funding opportunities, such as interactive
dashboards; and
(3) strategies to improve the ability of entities to apply for
SAMHSA funding opportunities, including entities that have not
traditionally applied for SAMHSA funding opportunities.
(c) Website Improvements.--The Secretary shall implement
improvements to Grants.gov related to SAMHSA funding opportunities
based on stakeholder feedback received at the public meeting under
subsection (a), as appropriate, to the maximum extent feasible.
(d) Report.--Not later than one year after the date on which the
public meeting under subsection (a) is convened, the Secretary shall
submit to the Committee on Health, Education, Labor, and Pensions of
the Senate and the Committee on Energy and Commerce of the House of
Representatives a report summarizing the findings of such meeting,
including how the Secretary has taken into account the feedback
received through such meeting and implemented--
(1) improvements to internet websites maintained by the
Secretary that provide information related to SAMHSA funding
opportunities; and
(2) strategies to improve awareness of SAMHSA funding
opportunities.

64fa07d584162080e75b3a5c93c3a1cd7638a328d01a473ee3ee5c06e5b3808f

PRESCRIBING PRACTITIONER.
Section 309A(a) of the Controlled Substances Act (21 U.S.C.
829a(a)) is amended by striking paragraph (2) and inserting the
following:
``(2) the controlled substance is a drug in schedule III, IV,
or V to be administered--
``(A) by injection or implantation for the purpose of
maintenance or detoxification treatment; or
``(B) subject to a risk evaluation and mitigation strategy
pursuant to section 505-1 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 355-1) that includes elements to assure
safe use of the drug described in subsection (f)(3)(E) of such
section, including a requirement for post-administration
monitoring by a health care provider;''.

8eb782a742be83408f39787f6e8e808f150bf391bf97f75e6899e11c72d84a4c

SUBSTANCES.
(a) In General.--Section 303 of the Controlled Substances Act (21
U.S.C. 823) is amended--
(1) by redesignating the second subsection designated as
subsection (l) as subsection (m); and
(2) in subsection (m)(1), as so redesignated--
(A) in subparagraph (A)--
(i) in clause (iv)--
(I) in subclause (I)--
(aa) by inserting ``the American Academy of
Family Physicians, the American Podiatric Medical
Association, the Academy of General Dentistry, the
American Optometric Association,'' before ``or any
other organization'';
(bb) by striking ``or the Commission'' and
inserting ``, the Commission''; and
(cc) by inserting ``, or the Council on
Podiatric Medical Education'' before the semicolon
at the end; and
(II) in subclause (III), by inserting ``or the
American Academy of Family Physicians'' after
``Association''; and
(ii) in clause (v), in the matter preceding subclause
(I)--
(I) by striking ``osteopathic medicine, dental
surgery'' and inserting ``osteopathic medicine,
podiatric medicine, dental surgery''; and
(II) by striking ``or dental medicine curriculum''
and inserting ``or dental or podiatric medicine
curriculum''; and
(B) in subparagraph (B)--
(i) in clause (i)--
(I) by inserting ``the American Pharmacists
Association, the Accreditation Council on Pharmacy
Education, the American Psychiatric Nurses Association,
the American Academy of Nursing, the American Academy
of Family Physicians,'' before ``or any other
organization''; and
(II) by inserting ``, the American Academy of
Family Physicians,'' before ``or the Accreditation
Council''; and
(ii) in clause (ii)--
(I) by striking ``or accredited school'' and
inserting ``, an accredited school''; and
(II) by inserting ``, or an accredited school of
pharmacy'' before ``in the United States''.
(b) Effective Date.--The amendment made by subsection (a) shall
take effect as if enacted on December 29, 2022.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.

6f2c02e6683212d16c5dd5a6798c46ea95c27b9af47662694bb6b30661d8d30a

SUPPORT for Patients and Communities Reauthorization Act of 2025 — HR. 2483

Other Sections

TITLE I

TITLE II

TITLE III

TITLE IV

Want the full experience?